Rheumatoid Arthritis

Study Title
Expected Compliance Profiles of the new Anti-Rheumatics, Infliximab and Etanercept

Study Group
Literature Review

Reminder Type
Telephone prompts and mail

Summary
Compliance with appointment reminders varied between 33% and 88%. Reminder systems consistently produce a significant, positive impact on patient compliance with medical IV infusions and appointments.

Citation
Jarry, Jose L., Ph.D., De Maio, Fernando G.;et., al., “Expected Compliance Profiles of the New Anti-Rheumatics, Infliximab and Etanercept,” 20th Congress of the International League of Associations for Rheumatology (ILAR), August 26-30, 2001, Edmonton, Alberta
http://www.healthpromoresearch.com/images/ILAR%20poster%20for%20print.pdf

Implement Patient-Focused Appointment Reminder Programs

There are 1.3 million adults in the United States with rheumatoid arthritis, which occurs in all races and ethnic groups. Compliance with appointments without reminder systems varied between 33% and 88%.